Keros Therapeutics (KROS) Net Cash Flow Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -1,488.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,488.37% |
| Sep 30, 2025 | -97.40% |
| Jun 30, 2025 | 17.10% |
| Mar 31, 2025 | 44.31% |
| Dec 31, 2024 | -32.38% |
| Sep 30, 2024 | 465.15% |
| Jun 30, 2024 | -24.41% |
| Mar 31, 2024 | 53.76% |
| Dec 31, 2023 | 9.17% |
| Sep 30, 2023 | -243.87% |
| Jun 30, 2023 | -126.79% |
| Mar 31, 2023 | 5,071.22% |
| Dec 31, 2022 | 355.84% |
| Sep 30, 2022 | 263.60% |
| Jun 30, 2022 | 28.33% |
| Mar 31, 2022 | 86.36% |
| Dec 31, 2021 | -93.42% |
| Sep 30, 2021 | -33.78% |
| Jun 30, 2021 | -120.06% |
| Mar 31, 2021 | -122.47% |
| Dec 31, 2020 | 2,495.97% |
| Sep 30, 2020 | -258.86% |
| Jun 30, 2020 | 1,834.35% |
| Mar 31, 2020 | 1,990.09% |